It’s the sole injectable buprenorphine that provides both equally weekly and every month dosing possibilities. BRIXADI is indicated for the treatment of average to severe opioid use ailment (OUD) in sufferers who have initiated treatment with just one dose of a transmucosal buprenorphine products or that are currently remaining taken care of with